{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:46:53Z","timestamp":1790790413485,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.smim.2017.08.014","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T10:45:12Z","timestamp":1504608312000},"page":"123-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":529,"special_numbering":"C","title":["Major findings and recent advances in virus\u2013like particle (VLP)-based vaccines"],"prefix":"10.1016","volume":"34","author":[{"given":"Mona O.","family":"Mohsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Cabral-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.smim.2017.08.014_bib0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.smim.2017.08.014_bib0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/BC.2008.064","article-title":"The coming of age of virus-like particle vaccines","volume":"389","author":"Jennings","year":"2008","journal-title":"Biol. Chem."},{"issue":"2","key":"10.1016\/j.smim.2017.08.014_bib0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/156652407780059140","article-title":"Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines","volume":"7","author":"Jennings","year":"2007","journal-title":"Curr. Mol. Med."},{"issue":"2","key":"10.1016\/j.smim.2017.08.014_bib0020","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-2836(77)80038-7","article-title":"Studies on the assembly of a spherical plant virus. III. Reassembly of infectious virus under mold conditions","volume":"109","author":"Adolph","year":"1977","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.smim.2017.08.014_bib0025","series-title":"Viral Nanotechnology","author":"Pumpens","year":"2016"},{"issue":"47","key":"10.1016\/j.smim.2017.08.014_bib0030","doi-asserted-by":"crossref","first-page":"11155","DOI":"10.1021\/bi901306p","article-title":"Assembly of hybrid bacteriophage Qbeta virus-like particles","volume":"48","author":"Brown","year":"2009","journal-title":"Biochemistry"},{"issue":"19","key":"10.1016\/j.smim.2017.08.014_bib0035","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1073\/pnas.91.19.9067","article-title":"Expression of tobacco mosaic virus coat protein and assembly of pseudovirus particles in Escherichia coli","volume":"91","author":"Hwang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2017.08.014_bib0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1756-0500-2-167","article-title":"Heterologous production of human papillomavirus type-16 L1 protein by a lactic acid bacterium","volume":"2","author":"Cortes-Perez","year":"2009","journal-title":"BMC Res. Notes"},{"issue":"2","key":"10.1016\/j.smim.2017.08.014_bib0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jbiotec.2006.10.005","article-title":"Expression and self-assembly of cowpea chlorotic mottle virus-like particles in Pseudomonas fluorescens","volume":"128","author":"Phelps","year":"2007","journal-title":"J. Biotechnol."},{"issue":"7","key":"10.1016\/j.smim.2017.08.014_bib0050","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.nano.2012.01.007","article-title":"Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles","volume":"8","author":"Zhao","year":"2012","journal-title":"Nanomedicine"},{"issue":"5599","key":"10.1016\/j.smim.2017.08.014_bib0055","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1126\/science.298.5599.1790","article-title":"N-linked glycosylation in Campylobacter jejuni and its functional transfer into E-coli","volume":"298","author":"Wacker","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.smim.2017.08.014_bib0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/hv.22218","article-title":"Plant-derived virus-like particles as vaccines","volume":"9","author":"Chen","year":"2013","journal-title":"Hum. Vaccines Immunotherapeutics"},{"issue":"2","key":"10.1016\/j.smim.2017.08.014_bib0065","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1006\/viro.1995.1283","article-title":"Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae","volume":"209","author":"Hofmann","year":"1995","journal-title":"Virology"},{"issue":"5872","key":"10.1016\/j.smim.2017.08.014_bib0070","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/298347a0","article-title":"Synthesis and assembly of hepatitis B virus surface antigen particles in yeast","volume":"298","author":"Valenzuela","year":"1982","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.smim.2017.08.014_bib0075","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.smim.2017.08.014_bib0080","article-title":"Assembly and release of hepatitis B virus","volume":"5","author":"Selzer","year":"2015","journal-title":"Cold Spring Harb. Perspect Med."},{"issue":"5321","key":"10.1016\/j.smim.2017.08.014_bib0085","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1126\/science.276.5321.2024","article-title":"The role of antibody concentration and avidity in antiviral protection","volume":"276","author":"Bachmann","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.smim.2017.08.014_bib0090","article-title":"Harnessing nanoparticles for immunomodulation and vaccines","volume":"5","author":"Gomes","year":"2017","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.smim.2017.08.014_bib0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2017.02.031","article-title":"Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination","volume":"251","author":"Mohsen","year":"2017","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.smim.2017.08.014_bib0100","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.4049\/jimmunol.1103312","article-title":"Innate immunity mediates follicular transport of particulate but not soluble protein antigen","volume":"188","author":"Link","year":"2012","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2017.08.014_bib0105","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4049\/jimmunol.161.3.1313","article-title":"Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response","volume":"161","author":"Wykes","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2017.08.014_bib0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/btm2.10049","article-title":"Virus-like particles: next-generation nanoparticles for targeted therapeutic delivery","volume":"2","author":"Rohovie","year":"2017","journal-title":"Bioeng. Transl. Med."},{"issue":"11","key":"10.1016\/j.smim.2017.08.014_bib0115","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.4049\/jimmunol.153.11.4925","article-title":"Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules","volume":"153","author":"Harding","year":"1994","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2017.08.014_bib0120","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1073\/pnas.90.11.4942","article-title":"Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages","volume":"90","author":"Kovacsovics-Bankowski","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.smim.2017.08.014_bib0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HJH.0b013e32800ff5d6","article-title":"A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity","volume":"25","author":"Ambuhl","year":"2007","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.smim.2017.08.014_bib0130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/eji.201142064","article-title":"Virus-like particles induce robust human T-helper cell responses","volume":"42","author":"Braun","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2017.08.014_bib0135","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/eji.201142361","article-title":"Nano-particle vaccination combined with TLR-7 and \u22129 ligands triggers memory and effector CD8(+) T-cell responses in melanoma patients","volume":"42","author":"Goldinger","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2017.08.014_bib0140","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/CJI.0b013e3181f1d614","article-title":"Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients","volume":"33","author":"Speiser","year":"2010","journal-title":"J. Immunother."},{"issue":"5","key":"10.1016\/j.smim.2017.08.014_bib0145","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"5138","key":"10.1016\/j.smim.2017.08.014_bib0150","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.8248784","article-title":"The influence of antigen organization on B cell responsiveness","volume":"262","author":"Bachmann","year":"1993","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.smim.2017.08.014_bib0155","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.immuni.2007.06.007","article-title":"B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node","volume":"27","author":"Carrasco","year":"2007","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.smim.2017.08.014_bib0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI11849","article-title":"Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies","volume":"108","author":"Chackerian","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.smim.2017.08.014_bib0165","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.4049\/jimmunol.178.11.7450","article-title":"A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis","volume":"178","author":"Spohn","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2017.08.014_bib0170","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fimmu.2017.00226","article-title":"Adjusted particle size eliminates the need of linkage of antigen and adjuvants for appropriated t cell responses in virus-Like particle-Based vaccines","volume":"8","author":"Gomes","year":"2017","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2017.08.014_bib0175","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrd2059","article-title":"Therapeutic potential of Toll-like receptor 9 activation","volume":"5","author":"Krieg","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.smim.2017.08.014_bib0180","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.4049\/jimmunol.172.3.1777","article-title":"Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects","volume":"172","author":"Storni","year":"2004","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2017.08.014_bib0185","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.4049\/jimmunol.0804004","article-title":"Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses","volume":"183","author":"Bessa","year":"2009","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.smim.2017.08.014_bib0190","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.4049\/jimmunol.0903949","article-title":"Cutting edge: IL-21 and TLR signaling regulate germinal center responses in a B cell-intrinsic manner","volume":"184","author":"Bessa","year":"2010","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2017.08.014_bib0195","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.4049\/jimmunol.178.4.2415","article-title":"TLR9 signaling in B cells determines class switch recombination to IgG2a","volume":"178","author":"Jegerlehner","year":"2007","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2017.08.014_bib0200","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1039\/c2nr30366c","article-title":"Development of viral nanoparticles for efficient intracellular delivery","volume":"4","author":"Wu","year":"2012","journal-title":"Nanoscale"},{"issue":"14","key":"10.1016\/j.smim.2017.08.014_bib0205","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1002\/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4","article-title":"A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective ligation of azides and terminal alkynes","volume":"41","author":"Rostovtsev","year":"2002","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"12","key":"10.1016\/j.smim.2017.08.014_bib0210","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1021\/acs.bioconjchem.5b00521","article-title":"Click chemistry applied to the synthesis of salmonella typhimurium O-Antigen glycoconjugate vaccine on solid phase with sugar recycling","volume":"26","author":"Stefanetti","year":"2015","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.smim.2017.08.014_bib0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/mp3002528","article-title":"In vivo virus-based macrofluorogenic probes target azide-labeled surface glycans in MCF-7 breast cancer cells","volume":"10","author":"Washington-Hughes","year":"2013","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.smim.2017.08.014_bib0220","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/cb400060x","article-title":"Boosting immunity to small tumor-associated carbohydrates with bacteriophage qbeta capsids","volume":"8","author":"Yin","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.smim.2017.08.014_bib0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/mp3002057","article-title":"CPMV-DOX delivers","volume":"10","author":"Aljabali","year":"2013","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.smim.2017.08.014_bib0230","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1021\/bm300590x","article-title":"Engineered mutations change the structure and stability of a virus-like particle","volume":"13","author":"Fiedler","year":"2012","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.smim.2017.08.014_bib0235","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1021\/cb3000265","article-title":"Tyrosine cross-linking reveals interfacial dynamics in adeno-associated viral capsids during infection","volume":"7","author":"Horowitz","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.smim.2017.08.014_bib0240","series-title":"Viral Nanotechnology","author":"Khudyakov","year":"2016"},{"issue":"2","key":"10.1016\/j.smim.2017.08.014_bib0245","doi-asserted-by":"crossref","first-page":"e1556","DOI":"10.1371\/journal.pone.0001556","article-title":"Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein","volume":"3","author":"Gregson","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2017.08.014_bib0250","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/srep00005","article-title":"SplitCore: an exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure","volume":"1","author":"Walker","year":"2011","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.smim.2017.08.014_bib0255","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s12033-015-9867-0","article-title":"SplitCore technology allows efficient production of virus-Like particles presenting a receptor-Contacting epitope of human IgE","volume":"57","author":"Baltabekova","year":"2015","journal-title":"Mol. Biotechnol."},{"issue":"4","key":"10.1016\/j.smim.2017.08.014_bib0260","doi-asserted-by":"crossref","first-page":"e0120751","DOI":"10.1371\/journal.pone.0120751","article-title":"Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteins","volume":"10","author":"Peyret","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.smim.2017.08.014_bib0265","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/bm400747k","article-title":"Carboxylate-directed in vivo assembly of virus-like nanorods and tubes for the display of functional peptides and residues","volume":"14","author":"Brown","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.smim.2017.08.014_bib0270","doi-asserted-by":"crossref","first-page":"19234","DOI":"10.1038\/srep19234","article-title":"Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization","volume":"6","author":"Brune","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.smim.2017.08.014_bib0275","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.smim.2017.08.014_bib0280","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.smim.2017.08.014_bib0285","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1021\/nn201397z","article-title":"Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles","volume":"5","author":"Ashley","year":"2011","journal-title":"ACS Nano"},{"issue":"6857","key":"10.1016\/j.smim.2017.08.014_bib0290","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.smim.2017.08.014_bib0295","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/eji.200323919","article-title":"Role of Toll-like receptors in costimulating cytotoxic T cell responses","volume":"33","author":"Schwarz","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"6813","key":"10.1016\/j.smim.2017.08.014_bib0300","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.smim.2017.08.014_bib0305","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2249.2003.02107.x","article-title":"CpG ODN enhances uptake of bacteria by mouse macrophages","volume":"132","author":"Utaisincharoen","year":"2003","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2017.08.014_bib0310","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/75365","article-title":"Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism","volume":"18","author":"Cho","year":"2000","journal-title":"Nat. Biotechnol."},{"issue":"17","key":"10.1016\/j.smim.2017.08.014_bib0315","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1182\/blood-2008-10-185421","article-title":"BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation","volume":"113","author":"Eckl-Dorna","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.smim.2017.08.014_bib0320","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jhep.2011.06.006","article-title":"Hepatitis B surface antigen quantification: why and how to use it in 2011 \u2212 a core group report","volume":"55","author":"Chan","year":"2011","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.smim.2017.08.014_bib0325","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00430-014-0374-x","article-title":"Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1\/Pre-S2\/S vaccine","volume":"204","author":"Shouval","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"issue":"4 Pt. 1","key":"10.1016\/j.smim.2017.08.014_bib0330","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1053\/jhep.2001.27564","article-title":"Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines","volume":"34","author":"Zuckerman","year":"2001","journal-title":"Hepatology"},{"issue":"8918","key":"10.1016\/j.smim.2017.08.014_bib0335","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(94)91384-6","article-title":"Specific vaccine therapy in chronic hepatitis B infection","volume":"344","author":"Pol","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2017.08.014_bib0340","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1475-2875-8-312","article-title":"Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data","volume":"8","author":"Moorthy","year":"2009","journal-title":"Malar. J."},{"issue":"10","key":"10.1016\/j.smim.2017.08.014_bib0345","doi-asserted-by":"crossref","first-page":"e25786","DOI":"10.1371\/journal.pone.0025786","article-title":"Circumsporozoite-specific T cell responses in children vaccinated with RTS,S\/AS01E and protection against P falciparum clinical malaria","volume":"6","author":"Olotu","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.smim.2017.08.014_bib0350","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1586\/erv.11.57","article-title":"The RTS,S vaccine candidate for malaria","volume":"10","author":"Regules","year":"2011","journal-title":"Expert Rev. Vaccines"},{"issue":"24","key":"10.1016\/j.smim.2017.08.014_bib0355","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","article-title":"A phase 3 trial of RTS,S\/AS01 malaria vaccine in African infants","volume":"367","author":"Rts","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.smim.2017.08.014_bib0360","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(13)70005-7","article-title":"Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data","volume":"13","author":"Bejon","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.smim.2017.08.014_bib0365","doi-asserted-by":"crossref","first-page":"46621","DOI":"10.1038\/srep46621","article-title":"Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine","volume":"7","author":"Collins","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2017.08.014_bib0370","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2147\/IJWH.S50365","article-title":"Long-term efficacy and safety of human papillomavirus vaccination","volume":"6","author":"De Vincenzo","year":"2014","journal-title":"Int. J. Womens Health"},{"key":"10.1016\/j.smim.2017.08.014_bib0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2017.04.004","article-title":"HPV vaccines \u2212 A review of the first decade","author":"Harper","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.smim.2017.08.014_bib0380","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40264-013-0039-5","article-title":"Safety of human papillomavirus vaccines: a review","volume":"36","author":"Macartney","year":"2013","journal-title":"Drug Saf."},{"issue":"19","key":"10.1016\/j.smim.2017.08.014_bib0385","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/j.vaccine.2007.01.106","article-title":"Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin","volume":"25","author":"Bright","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.smim.2017.08.014_bib0390","doi-asserted-by":"crossref","first-page":"e76571","DOI":"10.1371\/journal.pone.0076571","article-title":"Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine","volume":"8","author":"Skibinski","year":"2013","journal-title":"PLoS One"},{"issue":"39","key":"10.1016\/j.smim.2017.08.014_bib0395","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.vaccine.2014.07.011","article-title":"Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers","volume":"32","author":"Low","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.smim.2017.08.014_bib0400","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/infdis\/jiw259","article-title":"Rapid responses to 2 virus-Like particle norovirus vaccine candidate formulations in healthy adults: a randomized controlled trial","volume":"214","author":"Atmar","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.smim.2017.08.014_bib0405","first-page":"984","article-title":"Impact of pre-exposure history and host genetics on antibody avidity following norovirus vaccination","volume":"215","author":"Lindesmith","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.smim.2017.08.014_bib0410","doi-asserted-by":"crossref","first-page":"e0150146","DOI":"10.1371\/journal.pone.0150146","article-title":"Antibody persistence in adults two years after vaccination with an H1N1 2009 pandemic influenza virus-Like particle vaccine","volume":"11","author":"Valero-Pacheco","year":"2016","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.smim.2017.08.014_bib0415","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.vaccine.2015.06.047","article-title":"ISCOMATRIX adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans","volume":"33","author":"Chung","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.smim.2017.08.014_bib0420","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1086\/657087","article-title":"Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues","volume":"202","author":"El-Kamary","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"9959","key":"10.1016\/j.smim.2017.08.014_bib0425","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0140-6736(14)61185-5","article-title":"Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial","volume":"384","author":"Chang","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.smim.2017.08.014_bib0430","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/infdis\/jiw431","article-title":"A virus-Like particle vaccine elicits broad neutralizing antibody responses in humans to all chikungunya virus genotypes","volume":"214","author":"Goo","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.smim.2017.08.014_bib0435","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0163-4453(97)92814-0","article-title":"A pilot phase II study of the safety and immunogenicity of HIV p17\/p24:VLP (p24-VLP) in asymptomatic HIV seropositive subjects","volume":"35","author":"Peters","year":"1997","journal-title":"J. Infect."},{"issue":"4","key":"10.1016\/j.smim.2017.08.014_bib0440","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2222.2008.03191.x","article-title":"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I\/IIa clinical trial","volume":"39","author":"Senti","year":"2009","journal-title":"Clin. Exp. Allergy"},{"issue":"3","key":"10.1016\/j.smim.2017.08.014_bib0445","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jaci.2012.12.1561","article-title":"The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma","volume":"131","author":"Beeh","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2017.08.014_bib0450","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jaci.2006.01.040","article-title":"Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults","volume":"117","author":"Kundig","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9615","key":"10.1016\/j.smim.2017.08.014_bib0455","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(08)60381-5","article-title":"Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study","volume":"371","author":"Tissot","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.smim.2017.08.014_bib0460","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/eji.200526285","article-title":"A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity","volume":"35","author":"Maurer","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2017.08.014_bib0465","doi-asserted-by":"crossref","first-page":"e2547","DOI":"10.1371\/journal.pone.0002547","article-title":"A vaccine against nicotine for smoking cessation: a randomized controlled trial","volume":"3","author":"Cornuz","year":"2008","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.smim.2017.08.014_bib0470","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","article-title":"Safety, tolerability, and antibody response of active Abeta immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study","volume":"11","author":"Winblad","year":"2012","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.smim.2017.08.014_bib0475","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-015-0108-3","article-title":"Long-term treatment with active Abeta immunotherapy with CAD106 in mild Alzheimer's disease","volume":"7","author":"Farlow","year":"2015","journal-title":"Alzheimers Res. Ther."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532317300386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532317300386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T09:07:01Z","timestamp":1692954421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532317300386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":95,"alternative-id":["S1044532317300386"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2017.08.014","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Major findings and recent advances in virus\u2013like particle (VLP)-based vaccines","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2017.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}